Applied Therapeutics, Inc. (APLT) DCF Valuation

Applied Therapeutics, Inc. (APLT) Valoración de DCF

US | Healthcare | Biotechnology | NASDAQ
Applied Therapeutics, Inc. (APLT) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Applied Therapeutics, Inc. (APLT) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¿Busca calcular el valor intrínseco de la Terapéutica Aplicada, Inc.? Nuestra calculadora APLT DCF integra datos del mundo real con extensas características de personalización, lo que le permite ajustar los pronósticos y mejorar sus estrategias de inversión.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 10.0 10.0 10.0 10.0 10.0 10.0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -45.6 -94.5 -105.2 -82.1 -64.5 6.0 6.0 6.0 6.0 6.0
EBITDA, % 100 100 100 100 -645.8 60 60 60 60 60
Depreciation .0 .4 .4 .4 .0 8.0 8.0 8.0 8.0 8.0
Depreciation, % 100 100 100 100 0 80 80 80 80 80
EBIT -45.6 -94.8 -105.6 -82.5 -64.5 6.0 6.0 6.0 6.0 6.0
EBIT, % 100 100 100 100 -645.8 60 60 60 60 60
Total Cash 38.9 96.8 80.8 30.6 49.9 10.0 10.0 10.0 10.0 10.0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .5 .5 .3 .3
Account Receivables, % 100 100 100 100 2.85
Inventories .0 -.5 -.5 -.3 .0 8.0 8.0 8.0 8.0 8.0
Inventories, % 100 100 100 100 0 80 80 80 80 80
Accounts Payable 8.8 .6 9.5 4.5 1.7 8.3 8.3 8.3 8.3 8.3
Accounts Payable, % 100 100 100 100 17.43 83.49 83.49 83.49 83.49 83.49
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 0 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -45.5 -93.9 -104.6 -81.7 -64.5 6.0 6.0 6.0 6.0 6.0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -36.7 -101.7 -95.4 -86.2 -67.6 4.8 14.0 14.0 14.0 14.0
WACC, % 13.87 13.87 13.87 13.87 13.87 13.87 13.87 13.87 13.87 13.87
PV UFCF
SUM PV UFCF 40.0
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 14
Terminal Value 120
Present Terminal Value 63
Enterprise Value 103
Net Debt -49
Equity Value 152
Diluted Shares Outstanding, MM 84
Equity Value Per Share 1.80

What You Will Get

  • Real Applied Therapeutics Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures.
  • Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Applied Therapeutics’ fair value.
  • Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections.
  • Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility.

Key Features

  • 🔍 Real-Life APLT Financials: Pre-filled historical and projected data for Applied Therapeutics, Inc.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Applied Therapeutics’ intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Applied Therapeutics’ valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Applied Therapeutics data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Applied Therapeutics’ intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose the Applied Therapeutics Calculator?

  • Accuracy: Utilizes real Applied Therapeutics financials for precise data.
  • Flexibility: Allows users to easily test and adjust inputs as needed.
  • Time-Saving: Eliminate the complexity of creating a DCF model from the ground up.
  • Professional-Grade: Crafted with the precision and usability expected at the CFO level.
  • User-Friendly: Intuitive interface suitable for users with varying levels of financial modeling expertise.

Who Should Use Applied Therapeutics, Inc. (APLT)?

  • Investors: Gain insights into cutting-edge therapies and make informed investment choices.
  • Healthcare Analysts: Streamline your analysis with comprehensive data on innovative treatments.
  • Consultants: Easily modify reports and presentations to showcase the latest advancements in therapeutics.
  • Pharmaceutical Enthusiasts: Enhance your knowledge of drug development processes and market trends.
  • Educators and Students: Utilize it as a valuable resource for learning about biotechnology and pharmaceuticals.

What the Template Contains

  • Preloaded APLT Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.